The store will not work correctly when cookies are disabled.
5-Methyl-1H-[1,6]naphthyridin-2-one
ID: ALA2112000
PubChem CID: 10329832
Max Phase: Preclinical
Molecular Formula: C9H8N2O2
Molecular Weight: 176.17
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1c2ccc(=O)[nH]c2cc[n+]1[O-]
Standard InChI: InChI=1S/C9H8N2O2/c1-6-7-2-3-9(12)10-8(7)4-5-11(6)13/h2-5H,1H3,(H,10,12)
Standard InChI Key: AHRSWVMNWQOYPY-UHFFFAOYSA-N
Molfile:
RDKit 2D
13 14 0 0 0 0 0 0 0 0999 V2000
5.0359 -1.1687 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.7578 -2.3948 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4683 -1.9823 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0417 -1.9823 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7464 -0.7448 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4683 -1.1573 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7578 -3.2312 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0417 -3.6437 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.7464 0.0802 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.3312 -2.4062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3312 -3.2312 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4683 -3.6437 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0417 -4.4687 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 4 1 0
3 6 2 0
4 1 1 0
5 1 1 0
6 5 1 0
7 2 2 0
8 11 2 0
9 5 2 0
10 4 2 0
11 10 1 0
12 7 1 0
3 2 1 0
8 7 1 0
8 13 1 0
M CHG 2 8 1 13 -1
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 176.17 | Molecular Weight (Monoisotopic): 176.0586 | AlogP: 0.47 | #Rotatable Bonds: ┄ |
Polar Surface Area: 59.80 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 1.28 | CX LogP: -0.70 | CX LogD: -0.70 |
Aromatic Rings: 2 | Heavy Atoms: 13 | QED Weighted: 0.47 | Np Likeness Score: 0.16 |
References
1. Singh B, Lesher GY, Pluncket KC, Pagani ED, Bode DC, Bentley RG, Connell MJ, Hamel LT, Silver PJ.. (1992) Novel cAMP PDE III inhibitors: 1,6-naphthyridin-2(1H)-ones., 35 (26): [PMID:1336055] [10.1021/jm00104a012] |